Recent studies have highlighted that polymorphisms in genes such as FTO and the Melanocortin-4 Receptor gene (MC4R) influence susceptibility to post-treatment obesity, enabling risk stratification and personalized intervention planning [65]. The gene discussed is FTO; the disease is obesity disorder.